In 1941 Blalock in America published results of 6 thymectomies and the following year Sir Geoffrey Keynes carried out the first thymectomy at New End Hospital, Hampstead. This era started with many disadvantagesit was an entirely new field in surgery and anesthesia and the importance of pre-operative preparation and post-operative care was not fully appreciated. Not unexpectedly the early mortality rate was frightening, but it was entirely due to Sir Geoffrey Keynes's steadfastness and his firm belief in thymectomy as a treatment, ably supported by Mr J E Piercy, that most of the obstacles were overcome and we can now claim, in nontumour cases, an operative mortality in the region of 4 %. 751 9
Thymectomy is offered to most patients with myasthenia, the usual exceptions being: (1) Purely ocular myasthenia. (2) Gross contraindication to surgery or anasthesia, e.g. severe pulmonary disability. (3) Elderly patients with mild myasthenia who respond well to drugs. (4) Tumours of the thymus that had not been irradiated.
The Patient
It is a fact, and quite understandable, that most of these unfortunate patients develop an anxiety state about their disease. Their whole existence revolves round the bottle of tablets, which is never out of reach. On every symptom of lassitude or tiredness, irrespective of the cause, eyes are immediately cast in the direction of the tablets. It is vital that this frame of mind be understood and appreciated, and all efforts directed at reassurance and the establishment of confidence. Further, it must be explained to the patient that in the majority of sufferers the available cholinesterase inhibitors will not restore full muscular strength, and this fact is unfortunately not generally appreciated by the patient or even, on occasion, by the medical attendant. In the majority of patients, neostigmine and pyridostigmine will improve the patient's strength up to a certain point onlythe maximum response level (Lange 1966) and however much the dosage may be increased beyond this, increased strength will not occur. I cannot sufficiently stress this. With increasing doses of the cholinergic drugs muscarinic and nicotinic side-effects soon become apparent, and before long muscle weaknesses, due to toxic paralysis, are manifest. In the mistaken belief that this is due to the myasthenia, more drugs are given, usually with disastrous results.
The patient must accept that the drugs may not restore his strength fully and then, having accepted this, must learn to live with it and, if necessary, adapt his way of life accordingly.
Pre-operative Preparation
Myasthenia is considered one of the few diseases where a long period of inpatient preparation is indicated.
The first issue to decide is whether there is an associated tumour of the thymus present, in the event of which irradiation should first be carried out (Keynes 1954) . We believe this improves an already grim prognosis. A short progressive history with poor response to drugs, in the older type of patient, is suggestive of a tumour, but we rely entirely on our radiologist colleagues for confirmation.
Routine investigations include full blood counts, X-rays, pulmonary function tests, determining the presence or otherwise of muscle antibodies, &c. Physiotherapy forms an important aspect of the patient's daily routine.
Pari passu, by trial and error, the dose of drug is determined which will produce the maximum response level. Slowly and subtly the patient's confidence and morale are being built up. He should lead an active ward life and be encouraged to take part in activities such as handling mail and serving teas. At the psychological moment the doctor has a frank discussion with the patient, making him aware of the implications and, in particular, the vital necessity of his full cooperation after operation with special regard to the deep breathing and coughing sessions so necessary to ensure a smooth convalescence. The pattern of results following thymectomy is also indicated. As a rule the patient appreciates this frank discussion and full co-operation is then assured. If morale and confidence are not gained and the patient does not understand the important part he must play in the post-operative period, serious consideration should be given to postponing the operation and a further attempt considered in the future.
Operation and
Post-operative Care The operation takes place first thing in the morning. Four to five hours before the operation the patient takes an oral dose of the drug. One hour prior to operation the premedication is administered, usually Omnopon and scopolamine, and half an hour before an intramuscular injection of neostigmine equivalent to one dose (05-2 mg).
Anesthesia is induced with thiopentone and maintained with nitrous oxide, oxygen and fluothane and a cuffed endotracheal tube introduced. The operation is described in detail elsewhere (Piercy 1957 ). If the pre-operative pulmonary function tests had shown a low vital capacity or FEV serious consideration should be given to a tracheostomy at the time of thymectomy. Post-operative sedation should be nicely judged to relieve pain sufficiently and to encourage deep breathing and coughing, but not to depress respiration. Cholinesterase inhibitors are withheld until clinical evidence indicating the need thereof becomes evident. We believe that in this manner we have largely avoided the dreaded complication of a cholinergic crisis.
The patient has a special, fully trained nurse for the first four to five days and always at hand is an emergency set for immediate tracheostomy, a ventilator and oxygen. Semi-isolation nursing is adopted to minimize the risk of infection. Cough-I..n:eA" l 21 31 41 If this is not done, in an alarmingly short space of time the peripheral air passages become clogged, resulting in atelectasis and deficient ventilation with a gravely ill patient and probably a fatal termination. If this vicious circle appears to have started or be imminent, emergency tracheostomy should be carried out, the trachea aspirated and if necessary positive pressure ventilation instituted. Occasionally one is presented with a gravely ill patient in whom it may be virtually impossible to distinguish between a myasthenic and a cholinergic crisis. In such a situation the intravenous use of edrophonium is justified. A prompt improvement in the patient's condition points to a myasthenic state and the exhibition of more drugs, whilst a negative response or worsening of the patient's condition indicates a cholinergic crisis, the absolute veto to more drugs and the urgent institution of tracheostomy and ventilation. In default a fatal termination is virtually inevitable.
The patient is allowed up by the fifth day and discharged by the end of the second or third week. During the convalescent period the amount of drugs, if any, will have been suitably adjusted and the patient will have learned to vary his dosage within narrow limits to meet changing conditions, e.g. an extra tablet when a spell of Section ofRadiology increased activity is anticipated or, if mastication remains severely affected, an extra half or one tablet 45 minutes before each of the three main meals. By this time he has also learned to recognize the side-effects of the drugsabdominal discomfort, borborygmi, diarrhoea, sweating, &c., and that the development of these symptoms frequently indicates overdosage. For this reason, and because they may mask these warning symptoms, atropine and the modern anticholinergic drugs are seldom prescribed.
Review
At the Endocrine Unit of New End Hospital there are 260 patients recorded as suffering from myasthenia gravis (Table 1) ; 5 patients have been operated on in the past year and are not included in this review, whilst 7 patients have been lost trace of over the years though it is known that the majority of these were enjoying good health several years after thymectomy. There were 44 tumour cases (17 %). Table 2 indicates the sex distribution. Tumour cases tend to occur one or two decades later than the nontumour cases.
In a recent follow up of the 144 nontumour cases it was found that 77% had been followed up for ten years or longer, 61 % for fifteen years or longer and 26 % for twenty years or longer. The corresponding figures for tumour cases are: 50%, 20% and 0/%. In the 228 operation cases the mortality figures (Table 3) indicate the overall mortality, the remote deaths and the actual operative mortality. The overall mortality figure of 22 % in nontumour cases falls into three equal groups:
(1) Attributable to the operation, (2) from causes other than the disease, and (3) remote deaths as a result of the disease or cholinergic crisis; the latter appears to have occurred more often than necessary.
Categorization
In order to demonstrate the value of thymectomy four simple categories have been devised:
Category 1: Patients who appear to have been cured with return of full strength and leading a normal life and working with no need of drugs.
Minor stigmata may remainmild ptosis or a partially frozen facies. Category 2: Again the patient is restored to full strength but does require drugs. An affirmative answer to the question: Do you find that you are in any way incapacitated by virtue of the disease? immediately precludes categories 1 and 2. Category 3: Those patients in whom there is obvious muscular weakness in spite of taking the drugs. Category 4: Patients who may be able to look after themselves, feed and dress themselves, but are quite incapable of any additional effort. Table 4 shows the results of categorizing the 144 non-tumour cases prior to operation and again in a recent follow up. The obvious upgrading in physical strength of these patients needs no emphasis. One third appear to be completely cured and nearly 70 % are restored to a normal and full life. 
Conclusions
(1) Thymectomy is undoubtedly of value (Ross 1952 , Simpson 1958 ).
(2) The sooner this is carried out the better the prognosis (Lange 1960) , and this appears to be 12 irrespective of age and sex. Tumour cases should be irradiated before operation (Keynes 1954). (3) Careful pre-operative preparation and meticulous post-operative care are imperative.
(4) The possibility of overdosage, in fact the ease with which it may occur (cholinergic crisis), cannot be overstressed. In the majority of patients, unfortunately, we must accept that the currently available drugs will improve muscle strength up to a certain level onlythe maximum response level.
(5) Prompt tracheostomy, tracheal toilet and positive pressure ventilation will now salvage a fair proportion of these desperately ill patients.
Dr Louis Kreel (Royal Free Hospital, London)
Radiology in Myasthenia Gravis
The appearance of the prominent thymus in infancy (Caffey 1961) with widening of the superior mediastinum, the shadowing of which lies anteriorly, and the sail-shaped shadow on the right margin are well known. Similarly, the appearances of thymic tumours on plain film radiography and tomography have been well described (Harper & Guyer 1965) . Thymic tumours occur in the anterior mediastinum, on the right or left margins, are more prominent in the oblique views, may be as far down as the diaphragm and occasionally calcify. The shape of a thymic tumour is often characteristic, just as a kidney and a spleen, even when enlarged, have their characteristic shapes. This is illustrated in the occasional post-thymectomy patient when an effusion develops (Fig 1) . The distension of the residual space, the thymic bed, can be shown to have this characteristic thymic shape. It lies anteriorly and on the margins of the mediastinum.
Comparing thymic tumours with the basic shape, the similarity is immediately obvious and helps in distinguishing right-lobed tumours from aneurysms of the ascending aorta and left-lobed tumours from a prominent pulmonary artery. When a thymic tumour calcifies, unlike calcified cyst walls the calcification does not indicate the size of the tumour.
An interesting radiological observation is that the prominence in the region of the left main pulmonary artery so frequently seen in otherwise quite normal young adults, particularly females, is the left lobe of the thymus. This in normal subjects must be taken as a normal thymus, but in myasthenics may well represent a tumour.
In demonstrating thymic tumours, however small, it soon becomes clear that conventional radiographic techniques may be inadequate and do not overcome the previously mentioned difficulty in young women where the normal left lobe of the thymus can frequently be seen. Alternatively one should find a tumour in approximately 20 % of myasthenic patients because this is the overall incidence.
Anterior Pneumomediastinography
Anterior pneumomediastinography has proved of considerable value in detecting even small tumours, i.e. tumours measuring 2 x 1 x 1 cm (Kreel 1965) . Even a normal thymus can be shown so that its weight can be estimated.
Method
The method of this examination has been previously described (Kreel et al. 1964 , Kreel & James 1965 and only the main points will be referred to. The sternomanubrial joint is preferred for insertion of the needle which must be done in forced expiration to avoid pleural puncture and pneumothorax. The needle tip needs to be only 4-5 mm deep to the posterior wall of the sternum, just beyond the retrosternal fascia.
Between 350 and 500 ml of air is sufficient to show the thymus. The exact amount will depend on the appearances on screening the patient and on the patient's reaction. Few tumours will be detected on subsequent tomography which cannot be seen on fluoroscopy. The absence of a joint at the manubriosternal angle is no contraindication to this procedure. Whenever the patient's antimyasthenic medication is due, this must be administered.
Appearances on Pneumomediastinography By this means, a thymus can be shown to be normal or tumour free, whether this is in small thymuses as in older patients or in larger thymuses as in the younger age groups. The tumour-free thymus has parallel margins except near the apex.
Tumours are shown as curves or bulges on one or both borders of the thymus. On the lateral
